These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 18162763)

  • 1. E-cadherin/catenin complex status in solid pseudopapillary tumor of the pancreas.
    El-Bahrawy MA; Rowan A; Horncastle D; Tomlinson I; Theis BA; Russell RC; Stamp G
    Am J Surg Pathol; 2008 Jan; 32(1):1-7. PubMed ID: 18162763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of E-cadherin and cytoplasmic-nuclear expression of beta-catenin are the most useful immunoprofiles in the diagnosis of solid-pseudopapillary neoplasm of the pancreas.
    Kim MJ; Jang SJ; Yu E
    Hum Pathol; 2008 Feb; 39(2):251-8. PubMed ID: 17959228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear expression of E-cadherin in solid pseudopapillary tumors of the pancreas.
    Serra S; Salahshor S; Fagih M; Niakosari F; Radhi JM; Chetty R
    JOP; 2007 May; 8(3):296-303. PubMed ID: 17495358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane loss and aberrant nuclear localization of E-cadherin are consistent features of solid pseudopapillary tumour of the pancreas. An immunohistochemical study using two antibodies recognizing different domains of the E-cadherin molecule.
    Chetty R; Serra S
    Histopathology; 2008 Feb; 52(3):325-30. PubMed ID: 18269583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired E-cadherin expression and glutamine synthetase overexpression in solid pseudopapillary neoplasm of the pancreas.
    Audard V; Cavard C; Richa H; Infante M; Couvelard A; Sauvanet A; Terris B; Paye F; Flejou JF
    Pancreas; 2008 Jan; 36(1):80-3. PubMed ID: 18192886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of beta-catenin protein, mutations in exon-3 of the beta-catenin gene and a loss of heterozygosity of 5q22 in solid pseudopapillary tumor of the pancreas.
    Min Kim S; Sun CD; Park KC; Kim HG; Lee WJ; Choi SH
    J Surg Oncol; 2006 Oct; 94(5):418-25. PubMed ID: 16967453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression pattern of claudins 5 and 7 distinguishes solid-pseudopapillary from pancreatoblastoma, acinar cell and endocrine tumors of the pancreas.
    Comper F; Antonello D; Beghelli S; Gobbo S; Montagna L; Pederzoli P; Chilosi M; Scarpa A
    Am J Surg Pathol; 2009 May; 33(5):768-74. PubMed ID: 19194274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E-cadherin/beta-catenin and CD10: a limited immunohistochemical panel to distinguish pancreatic endocrine neoplasm from solid pseudopapillary neoplasm of the pancreas on endoscopic ultrasound-guided fine-needle aspirates of the pancreas.
    Burford H; Baloch Z; Liu X; Jhala D; Siegal GP; Jhala N
    Am J Clin Pathol; 2009 Dec; 132(6):831-9. PubMed ID: 19926573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent beta-catenin mutation and cytoplasmic/nuclear accumulation in pancreatic solid-pseudopapillary neoplasm.
    Tanaka Y; Kato K; Notohara K; Hojo H; Ijiri R; Miyake T; Nagahara N; Sasaki F; Kitagawa N; Nakatani Y; Kobayashi Y
    Cancer Res; 2001 Dec; 61(23):8401-4. PubMed ID: 11731417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors.
    Chetty R; Serra S; Asa SL
    Am J Surg Pathol; 2008 Mar; 32(3):413-9. PubMed ID: 18300809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical expression of beta-catenin, E-cadherin, cyclin D1 and c-myc in benign trichogenic tumors.
    Demirkan NC; Bir F; Erdem O; Düzcan E
    J Cutan Pathol; 2007 Jun; 34(6):467-73. PubMed ID: 17518774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological analysis of β-catenin and Axin-1 in solid pseudopapillary neoplasms of the pancreas.
    Huang SC; Ng KF; Yeh TS; Chang HC; Su CY; Chen TC
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S438-46. PubMed ID: 21769465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cadherin/catenin complex appears to be intact in hepatocellular carcinomas from Australia and South Africa.
    Herath NI; Walsh MD; Kew MC; Young J; Leggett BA; Macdonald GA
    J Gastroenterol Hepatol; 2004 Jun; 19(6):676-82. PubMed ID: 15151624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of cadherins and catenins correlates with distinct histologic types of ovarian carcinomas.
    Sarrió D; Moreno-Bueno G; Sánchez-Estévez C; Bañón-Rodríguez I; Hernández-Cortés G; Hardisson D; Palacios J
    Hum Pathol; 2006 Aug; 37(8):1042-9. PubMed ID: 16867867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-cystic solid-pseudopapillary tumor of the pancreas showing nuclear accumulation and activating gene mutation of beta-catenin.
    Nishimori I; Kohsaki T; Tochika N; Takeuchi T; Minakuchi T; Okabayashi T; Kobayashi M; Hanazaki K; Onishi S
    Pathol Int; 2006 Nov; 56(11):707-11. PubMed ID: 17040296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear E-cadherin immunoexpression: from biology to potential applications in diagnostic pathology.
    Chetty R; Serra S
    Adv Anat Pathol; 2008 Jul; 15(4):234-40. PubMed ID: 18580099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic inactivation of the E-cadherin gene in eyelid sebaceous gland carcinoma.
    Jayaraj P; Sen S; Sharma A; Chosdol K; Kashyap S; Rai A; Pushker N; Bajaj MS; Ghose S
    Br J Dermatol; 2012 Sep; 167(3):583-90. PubMed ID: 22458737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-catenin and E-cadherin expression in salivary gland tumors.
    Furuse C; Cury PR; Altemani A; dos Santos Pinto D; de Araújo NS; de Araújo VC
    Int J Surg Pathol; 2006 Jul; 14(3):212-7. PubMed ID: 16959701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum response factor enhances liver metastasis of colorectal carcinoma via alteration of the E-cadherin/beta-catenin complex.
    Choi HN; Kim KR; Lee JH; Park HS; Jang KY; Chung MJ; Hwang SE; Yu HC; Moon WS
    Oncol Rep; 2009 Jan; 21(1):57-63. PubMed ID: 19082443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant expression of E-cadherin and beta-catenin in human prostate cancer.
    Jaggi M; Johansson SL; Baker JJ; Smith LM; Galich A; Balaji KC
    Urol Oncol; 2005; 23(6):402-6. PubMed ID: 16301117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.